your symptoms happen when you come into contact with an asthma trigger, like pollen or animals or when you have a cold or ...

The study, called the ABRA trial, was led by King’s College London researchers and published in The Lancet Respiratory ...

Benralizabam, a monoclonal antibody, did a better job than steroids at reducing respiratory symptoms like coughing, wheezing, ...

Scientists discover benralizumab could tackle suffocating attacks for people with both asthma and chronic obstructive ...

Researchers at King's College London have discovered a groundbreaking asthma treatment, Benralizumab, the first of its kind ...

More than five million people in the UK suffer from asthma, but a new drug called benralizumab could change the game.

The study demonstrated that asthma treatment is safe, with no significant side effects compared to past studies of the drug.

Benralizumab is a monoclonal antibody that targets specific white blood cells, called eosinophils, to reduce lung ...

Scientists have found a new treatment for people with asthma and chronic obstructive pulmonary disease (COPD) that may be more effective than current options. Over the past 50 years, treatment options ...

The first new treatment for asthma attacks in 50 years has been hailed as a "game-changer" by doctors and patients.

Scientists say this is the first new way of treating the attacks in 50 years despite 3.8 million deaths across the world ...

A new way of treating serious asthma and chronic obstructive pulmonary disease (COPD) attacks could be a "game-changer" ...